EU TRANSPARENCY REGISTER · 438972049913-07 · Belgium

argenx

Category

Companies & groups

Country

Belgium

Ghent

Entity form

bv

Stated objectives

We are a commercial-stage, global, fully-integrated biopharma company developing a deep pipeline of differentiated therapies for the treatment of severe autoimmune diseases. By combining our suite of antibody engineering technologies with t…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2023-04-21

Last updated

2026-05-07

Other Companies & groups in Belgium

Other registered organisations in Belgium

Frequently asked questions

What is this organisation?
argenx is an interest representative listed in the EU Joint Transparency Register under ID 438972049913-07. Entity form: bv.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in Belgium, Ghent.
What are its stated goals?
As declared by the registrant: We are a commercial-stage, global, fully-integrated biopharma company developing a deep pipeline of differentiated therapies for the treatment of severe autoimmune diseases. By combining our suite of antibody engineering technologies with t…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 438972049913-07.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-01 · Commission Reuse Decision 2011/833/EU